ISCT 2022: an interview with Jon Rowley

Written by RegMedNet

We spoke with Jon Rowley, Founder and Chief Product Officer of RoosterBio (MD, USA), about ISCT 2022. Rowley discussed what he is most looking forward to at ISCT this year, how RoosterBio has developed over the last few years and the obstacles to developing cell-based therapies that are cost effective. Please introduce yourself and give an overview of your current role. My name is Jon Rowley and I am the Founder and Chief Product Officer of RoosterBio. My role is to oversee product strategy, product and process development, and aligning the technical and business strategy with the needs of our...

To view this content, please register now for access

It's completely free